Therefore, to determine whether the inhibition of NRF2 activity induced by DPP3 knockdown in EC cells directly translated into the alteration of drug sensitivity in these cells, we determined the relative drug sensitivity of the ESCC cells after DPP3 knockdown. This evidence concerns the gene NFE2L2 and esophageal squamous cell carcinoma.